Literature DB >> 12034345

Expression of matrix metalloproteinases in ovarian endometriomas: immunohistochemical study and enzyme immunoassay.

Hisanobu Mizumoto1, Tsuyoshi Saito, Koji Ashihara, Makoto Nishimura, Masaki Takehara, Ryoichi Tanaka, Eiki Ito, Ryuichi Kudo.   

Abstract

Like carcinoma, endometriosis has the unique characteristics, of invasion and metastasis, though pathologically, it is a benign tumor. However, the mechanism of destruction of the surrounding tissue in endometriosis is still unclear. In this study, the expression and localization of matrix metalloproteinases (MMP)-1, -2, -3, -7, -9 and tissue inhibitors of metalloproteinases-1 (TIMP-1) were evaluated by immunohistochemistry for 20 cases and the amounts of MMP-1, TIMP-1 and MMP-1/TIMP-1 complex in the fluid of endometrioma, were analyzed by ELISA and western blotting for 20 cases, which were analyzed by immunohistochemical study. MMP-1, -2 and -9 were detected strongly in both stromal and epithelial cells and MMP-7 in the epithelial cells in the menstrual period. MMP-3 was mainly expressed in macrophage containing hemosiderin but the change of expression was not clear. TIMP-1 was intensively detected in both stromal and epithelial cells in the menstrual period but the expression decreased in other stages of the menstrual cycle. ELISA for MMP-1 also showed results similar to immunohistochemistry, suggesting that it was released to the cyst in the menstrual period when it was released to the extracellular space from the cytoplasm. The expression of TIMP-1 was not clearly changed during the menstrual cycle. From these results, it was suggested that the destruction of the surrounding matrix by endometriosis might be caused by various MMPs, which are mainly produced in stromal cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034345     DOI: 10.1016/s0024-3205(02)01641-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agent.

Authors:  Patricia A Perone; Stephanie L Weber; Marissa DaSilva; Tejaswi Paruchuri; Narasimharao Bhagavathula; Muhammad N Aslam; Michael K Dame; Kent J Johnson; Richard D Swartz; James Varani
Journal:  Invest Radiol       Date:  2010-01       Impact factor: 6.016

2.  Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.

Authors:  Catherine Uzan; Annie Cortez; Charlotte Dufournet; Raffaèle Fauvet; Jean-Pierre Siffroi; Emile Daraï
Journal:  Virchows Arch       Date:  2004-09-28       Impact factor: 4.064

Review 3.  The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review).

Authors:  Magdalenia Bałkowiec; Radosław B Maksym; Paweł K Włodarski
Journal:  Mol Med Rep       Date:  2018-07-23       Impact factor: 2.952

4.  Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?

Authors:  Shaojie Ding; Qiao Lin; Tianhong Zhu; Tiantian Li; Libo Zhu; Jianzhang Wang; Xinmei Zhang
Journal:  BMC Womens Health       Date:  2019-12-30       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.